This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Richard Woodbury: Innovator in Blood Coagulation Factors
Introduction
Richard Woodbury is a notable inventor based in Dover, NH (US). He has made significant contributions to the field of blood coagulation through his innovative research and development. His work focuses on modified blood coagulation factors, which are crucial for various medical applications.
Latest Patents
Richard Woodbury holds a patent for a modified factor VII/VIIa. This application relates to modified blood coagulation factors, DNA sequences coding for such modified factors, and a process for their production. His invention plays a vital role in enhancing the effectiveness of treatments related to blood coagulation disorders.
Career Highlights
Richard Woodbury is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk A/S allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in medical science.
Collaborations
Richard has worked alongside talented colleagues, including Else Marie Nicolaisen and So Slashedren Bjo Slashedrn. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.
Conclusion
Richard Woodbury's contributions to the field of blood coagulation factors exemplify the impact of innovative thinking in medicine. His patent and work at Novo Nordisk A/S highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile